Allergy Relief Eye Drops Market

Global Allergy Relief Eye Drops Market Size, Share & Trends Analysis Report, By Drug Class (Antihistamines, Non-steroidal anti-Inflammatory Drugs, Vasoconstrictors, Others), By Type (Seasonal and Perennial Allergic Conjunctivitis, Vernal Keratoconjunctivitis, Atopic Keratoconjunctivitis, Giant Papillary Conjunctivitis, Others) Forecast (2021-2027)
    Update Available - Forecast 2024-2030   

Published: Jul 2023 | Report Code: OMR2025233 | Category : Pharmaceuticals | Delivery Format: /

The global allergy relief eye drops market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The rise in the geriatric patients’ population, coupled with the awareness about minor eye disorders are the pivotal factors affecting the growth of the global allergy relief eye drops market. The geriatric population is already considered to be more prone to suffer from eye diseases. In addition to this, there are high unmet medical needs related to eye care which are further anticipated to augment the global market growth. Eye drops are used to treat various eye-related issues such as eye redness, itching, dryness in the eyes, infection, allergies, swelling, and soreness, among others. 

Among these, allergy-related disorders have substantially grown in the past few years owing to the high adoption of digital devices, and pollutants. Such factors have led to the surge in the demand for allergy relief eye drops as the primary form of treatment. Further, growth in the working populations is also leading to several forms of eye-related allergies. Thus, eye drops and lubricants come to the rescue as they are an easily accessible form of treatment, less painful and can be used for various other eye-related problems.

Some key players operating in the market include Johnson & Johnson, Novartis AG, Bausch Health, Santen Pharmaceutical Co., Ltd., AbbVie Inc. among others. These players are aiming to strengthen their position in the market by adopting various strategies as mergers and acquisitions, partnerships, collaborations, new product launches and development in the existing product portfolio, and so on.

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment Covered
  • Regions Covered- Globally

Competitive Landscape: Johnson & Johnson, Novartis AG, Bausch Health, Santen Pharmaceutical Co., Ltd., AbbVie Inc. 

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominates the market in base year?
  • Which segment and region will project fastest growth in the market?
  • How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Allergy Relief Eye Drops Market by Segments

By Drug Class 

Antihistamines

Non-steroidal anti-Inflammatory Drugs

Vasoconstrictors

Others

By Type 

Seasonal and Perennial Allergic Conjunctivitis

Vernal Keratoconjunctivitis

Atopic Keratoconjunctivitis

Giant Papillary Conjunctivitis,

Others

Global Allergy Relief Eye Drops Market by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World